SirTLab company was founded by Mr. Boaz Misholi, a pioneering figure in Israel’s high-tech industry and Professor Haim Cohen from Bar-Ilan University in Israel, with the purpose of harnessing the groundbreaking findings on SIRT6 protein and its potential to promote a healthy lifespan.
During his research on SIRT6, Prof Haim Cohen, has demonstrated that increasing the levels of SIRT6 protein extend mice lifespan and delay the onset of age-related diseases by enhancing DNA repair, improving metabolic health, reduce inflammation, prevents frailty, and maintain young-like physical activity, all of which contribute to healthy aging (Nature Communications volume 12, Article number: 3208 (2021) ).
As we grow older, our bodies experience a multitude of physiological changes that elevate the susceptibility to chronic diseases and functional decline. These changes have a profound effect on an individual’s independence and overall well-being.
As a company, we have a profound understanding of the challenges and the pressing necessity to develop robust strategies that greatly enhance the quality of life, enabling individuals to lead fulfilling and highly productive lives during their golden years.
Our team of highly skilled scientists and researchers, invest heavily in research and development, to bring cutting-edge technologies based on increasing the activity of SIRT6 protein to revolutionize the concept of healthy aging.
The company is focused on longevity, liver diseases, metabolic syndrome as well as neurodegeneration and inflammatory conditions.
We are driven by a mission to improve the quality of life for elderly people. We believe that by harnessing the power of biotechnology, we can unlock new avenues for extending healthy lifespan, promoting healthy aging, and preventing age-related diseases and disabilities.
Our vision is to be at the forefront of the biotech industry, leading the way in developing groundbreaking therapies that make a real difference in people’s lives.